Objective: To evaluate hand osteoarthritis tools for core instrument set development. Methods: For OMERACT 2018, a systematic literature review and advances in instrument validation were presented. Results: Visual analog and numerical rating scales were considered valuable for pain and patient’s global assessment, despite heterogeneous phrasing and missing psychometric evidence for some aspects. The Modified Intermittent and Constant Osteoarthritis Pain scale was lacking evidence. The Michigan Hand Outcomes Questionnaire had advantages above other pain/function questionnaires. The Hand Mobility in Scleroderma scale was valid, although responsiveness was questioned. Potential joint activity instruments were evaluated. Conclusion: Th...
Problem Complement is a central defence against sepsis, and increasing complement insufficiency in n...
Problem Complement is a central defence against sepsis, and increasing complement insufficiency in n...
A major drawback of tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) is t...
Despite extensive years of research, the direct oxidation of the 7,8-double bond of opioids has so f...
Denitrification is a key process responsible for the majority of soil nitrous oxide (N2O) emissions ...
Diagnosis of developmental or congenital prosopagnosia (CP) involves self-report of everyday face re...
High mobility group box 1 (HMGB1) is a non-histone protein localised in the cell nucleus, where it i...
Environmental stability is a common challenge for the commercialisation of low cost, encapsulation-f...
We recently demonstrated that SB269652 (1) engages one protomer of a dopamine D2 receptor (D2R) dime...
Problem Complement is a central defence against sepsis, and increasing complement insufficiency in n...
With immunochemotherapy, remission duration and survival in patients with CLL is dependent on the le...
This study investigated how sample size affects the reproducibility of findings from univariate voxe...
OBJECTIVES: There are many rapid review methods; however, there is little pragmatic guidance on whi...
Environmental stability is a common challenge for the commercialisation of low cost, encapsulation-f...
Environmental stability is a common challenge for the commercialisation of low cost, encapsulation-f...
Problem Complement is a central defence against sepsis, and increasing complement insufficiency in n...
Problem Complement is a central defence against sepsis, and increasing complement insufficiency in n...
A major drawback of tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) is t...
Despite extensive years of research, the direct oxidation of the 7,8-double bond of opioids has so f...
Denitrification is a key process responsible for the majority of soil nitrous oxide (N2O) emissions ...
Diagnosis of developmental or congenital prosopagnosia (CP) involves self-report of everyday face re...
High mobility group box 1 (HMGB1) is a non-histone protein localised in the cell nucleus, where it i...
Environmental stability is a common challenge for the commercialisation of low cost, encapsulation-f...
We recently demonstrated that SB269652 (1) engages one protomer of a dopamine D2 receptor (D2R) dime...
Problem Complement is a central defence against sepsis, and increasing complement insufficiency in n...
With immunochemotherapy, remission duration and survival in patients with CLL is dependent on the le...
This study investigated how sample size affects the reproducibility of findings from univariate voxe...
OBJECTIVES: There are many rapid review methods; however, there is little pragmatic guidance on whi...
Environmental stability is a common challenge for the commercialisation of low cost, encapsulation-f...
Environmental stability is a common challenge for the commercialisation of low cost, encapsulation-f...
Problem Complement is a central defence against sepsis, and increasing complement insufficiency in n...
Problem Complement is a central defence against sepsis, and increasing complement insufficiency in n...
A major drawback of tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) is t...